company background image
ARAY logo

Accuray NasdaqGS:ARAY Stock Report

Last Price

US$1.85

Market Cap

US$186.0m

7D

-3.6%

1Y

-35.5%

Updated

22 Dec, 2024

Data

Company Financials +

Accuray Incorporated

NasdaqGS:ARAY Stock Report

Market Cap: US$186.0m

ARAY Stock Overview

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. More details

ARAY fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Accuray Incorporated Competitors

Price History & Performance

Summary of share price highs, lows and changes for Accuray
Historical stock prices
Current Share PriceUS$1.85
52 Week HighUS$3.05
52 Week LowUS$1.40
Beta1.46
1 Month Change-4.15%
3 Month Change4.52%
1 Year Change-35.54%
3 Year Change-62.17%
5 Year Change-34.40%
Change since IPO-93.50%

Recent News & Updates

Health Check: How Prudently Does Accuray (NASDAQ:ARAY) Use Debt?

Dec 19
Health Check: How Prudently Does Accuray (NASDAQ:ARAY) Use Debt?

Accuray Incorporated: Cheap, But With Caveats

Dec 05

Recent updates

Health Check: How Prudently Does Accuray (NASDAQ:ARAY) Use Debt?

Dec 19
Health Check: How Prudently Does Accuray (NASDAQ:ARAY) Use Debt?

Accuray Incorporated: Cheap, But With Caveats

Dec 05

Accuray Remains A Perpetual 'Next Year Is Our Year' Story

Aug 18

Accuray Incorporated's (NASDAQ:ARAY) 28% Dip In Price Shows Sentiment Is Matching Revenues

Aug 13
Accuray Incorporated's (NASDAQ:ARAY) 28% Dip In Price Shows Sentiment Is Matching Revenues

Lacklustre Performance Is Driving Accuray Incorporated's (NASDAQ:ARAY) 25% Price Drop

May 21
Lacklustre Performance Is Driving Accuray Incorporated's (NASDAQ:ARAY) 25% Price Drop

Analysts Have Lowered Expectations For Accuray Incorporated (NASDAQ:ARAY) After Its Latest Results

May 04
Analysts Have Lowered Expectations For Accuray Incorporated (NASDAQ:ARAY) After Its Latest Results

Are Investors Undervaluing Accuray Incorporated (NASDAQ:ARAY) By 25%?

May 03
Are Investors Undervaluing Accuray Incorporated (NASDAQ:ARAY) By 25%?

Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp

Apr 07

Is Accuray (NASDAQ:ARAY) A Risky Investment?

Feb 03
Is Accuray (NASDAQ:ARAY) A Risky Investment?

Why Investors Shouldn't Be Surprised By Accuray Incorporated's (NASDAQ:ARAY) 26% Share Price Plunge

Aug 17
Why Investors Shouldn't Be Surprised By Accuray Incorporated's (NASDAQ:ARAY) 26% Share Price Plunge

These 4 Measures Indicate That Accuray (NASDAQ:ARAY) Is Using Debt Extensively

Apr 13
These 4 Measures Indicate That Accuray (NASDAQ:ARAY) Is Using Debt Extensively

The Return Trends At Accuray (NASDAQ:ARAY) Look Promising

Mar 14
The Return Trends At Accuray (NASDAQ:ARAY) Look Promising

Accuray (NASDAQ:ARAY) Takes On Some Risk With Its Use Of Debt

Dec 01
Accuray (NASDAQ:ARAY) Takes On Some Risk With Its Use Of Debt

Accuray (NASDAQ:ARAY) Is Doing The Right Things To Multiply Its Share Price

Oct 27
Accuray (NASDAQ:ARAY) Is Doing The Right Things To Multiply Its Share Price

Accuray launches CyberKnife platform in Africa for cancer patients

Sep 30

Accuray GAAP EPS of -$0.04 beats by $0.03, revenue of $110.02M beats by $4.7M

Aug 10

Here's Why Accuray (NASDAQ:ARAY) Has A Meaningful Debt Burden

Jul 08
Here's Why Accuray (NASDAQ:ARAY) Has A Meaningful Debt Burden

Accuray (NASDAQ:ARAY) Might Have The Makings Of A Multi-Bagger

Jun 15
Accuray (NASDAQ:ARAY) Might Have The Makings Of A Multi-Bagger

Accuray: Nothing Special

May 31

Shareholder Returns

ARAYUS Medical EquipmentUS Market
7D-3.6%-1.5%-2.4%
1Y-35.5%10.0%23.4%

Return vs Industry: ARAY underperformed the US Medical Equipment industry which returned 10% over the past year.

Return vs Market: ARAY underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is ARAY's price volatile compared to industry and market?
ARAY volatility
ARAY Average Weekly Movement8.8%
Medical Equipment Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: ARAY has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ARAY's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990987Suzanne Winterwww.accuray.com

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

Accuray Incorporated Fundamentals Summary

How do Accuray's earnings and revenue compare to its market cap?
ARAY fundamental statistics
Market capUS$186.05m
Earnings (TTM)-US$16.53m
Revenue (TTM)US$444.20m

0.4x

P/S Ratio

-11.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ARAY income statement (TTM)
RevenueUS$444.20m
Cost of RevenueUS$306.11m
Gross ProfitUS$138.10m
Other ExpensesUS$154.63m
Earnings-US$16.53m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.16
Gross Margin31.09%
Net Profit Margin-3.72%
Debt/Equity Ratio376.4%

How did ARAY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:58
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Accuray Incorporated is covered by 24 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason WittesAegis Capital Corporation
Jason WittesBrean Capital
Neil ChatterjiB. Riley Securities, Inc.